Position in NVAX
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$155,090
-$22,484 QoQ
Shares Held
16,464
-24.5% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#143
of 263 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Derivatives in NVAX
reported options exposure · as of Jun 30, 2022CallValue
$1,080,030
CallShares
21,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Leonteq Securities AG holds $31,064,274 across 57 Biotechnology names. NVAX ranks #17 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
267,131 | $18,707,183 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,948 | $2,461,735 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,433 | $2,202,004 | |
| 4 | BNTX |
BioNTech SE
|
11,461 | $1,066,446 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
27,926 | $958,420 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
2,616 | $640,318 | |
| 7 | IOVA |
Iovance Biotherapeutics, Inc.
|
150,000 | $624,000 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
15,457 | $602,977 |
All Filings in NVAX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $155,090 | 16,464 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $177,574 | 21,815 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $217,183 | 32,319 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $268,743 | 30,997 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $336,281 | 53,378 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $487,794 | 76,099 | Shares | Sole | 2026-02-23 | |
| 2024-12-31 | $541,429 | 67,342 | Shares | Sole | 2026-02-23 | |
| 2024-09-30 | $525,610 | 41,616 | Shares | Sole | 2026-03-04 | |
| 2024-06-30 | $457,469 | 36,135 | Shares | Sole | 2026-03-04 | |
| 2024-03-31 | $1,038,531 | 217,266 | Shares | Sole | 2026-03-11 | |
| 2023-12-31 | $988,732 | 205,986 | Shares | Sole | 2026-03-11 | |
| 2023-09-30 | $771,088 | 106,504 | Shares | Sole | 2026-03-11 | |
| 2023-06-30 | $451,803 | 60,808 | Shares | Sole | 2026-03-11 | |
| 2023-03-31 | $579,597 | 83,636 | Shares | Sole | 2026-03-11 | |
| 2022-12-31 | $852,068 | 82,886 | Shares | Sole | 2026-03-26 | |
| 2022-09-30 | $1,662,060 | 91,322 | Shares | Sole | 2026-03-26 | |
| 2022-06-30 | $1,080,030 | 21,000 | Call | Sole | 2026-03-26 | |
| 2022-06-30 | $4,547,852 | 88,428 | Shares | Sole | 2026-03-26 | |
| 2022-03-31 | $9,404,147 | 127,687 | Shares | Sole | 2026-03-26 | |
| 2022-03-31 | $1,473,000 | 20,000 | Call | Sole | 2026-03-26 | |
| 2021-12-31 | $11,903,853 | 83,203 | Shares | Sole | 2026-03-26 | |
| 2021-09-30 | $4,443,275 | 21,433 | Shares | Sole | 2026-03-26 | |
| 2021-06-30 | $2,057,920 | 9,693 | Shares | Sole | 2026-03-26 | |
| 2021-03-31 | $486,454 | 2,683 | Shares | Sole | 2026-03-26 | |
| 2020-12-31 | $471,129 | 4,225 | Shares | Sole | 2026-03-26 | |
| No filing history on record for this holder in this stock. | ||||||